| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Wave Life Sciences Ltd. (WVE) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. WVE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 26.98M | $162.39M | - | |
| Dir | 5.73M | $34.49M | - | |
| Other | 408.2K | $2.46M | - | |
| Dir | 283.2K | $1.70M | - | |
| CEO | 275.5K | $1.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2019 | Panzara Michael A. | Franchise Lead, Neurology | Sell | 1,837 | $36.84 | $67,673.98 | -4.7% | |
| Feb 19, 2019 | Bolno Paul64 | President And CEO | Sell | 7,733 | $36.40 | $281,455.77 | -1.4% | |
| Feb 19, 2019 | Vargeese Chandra | Senior VP, Drug Discovery | Sell | 2,055 | $36.84 | $75,706.20 | -7.5% | |
| Feb 19, 2019 | Francis Chris70 | See Remarks | Sell | 1,709 | $36.84 | $62,959.05 | -7.7% | |
| Jan 24, 2019 | Ra Capital Management, LLC52 | Director, 10% Owner | Buy | 263,158 | $38.00 | $10,000,004.00 | +3.5% | |
| Nov 14, 2018 | Verdine Gregory L.63 | Director | Sell | 15,000 | $38.86 | $582,849.00 | -10.8% | |
| Sep 25, 2018 | Francis Chris70 | See Remarks | Sale+OE | 11,575 | $56.00 | $648,200.00 | -20.8% | |
| Sep 24, 2018 | Regnante Keith | Chief Financial Officer | Sale+OE | 29,500 | $55.00 | $1,622,500.00 | -63.5% | |
| Sep 24, 2018 | Vargeese Chandra | Senior VP, Drug Discovery | Sale+OE | 3,000 | $55.00 | $165,000.00 | -9.9% | |
| Jul 9, 2018 | Francis Chris70 | See Remarks | Sale+OE | 24,496 | $37.27 | $913,054.12 | -35.7% |